APO Research
Talk to an analyst

APO RESEARCH · REPORT

Severe Allergy Treatment Injection

Compare research editions
View pricing & licenses

Selected research

Industry Research

Severe Allergy Treatment Injection Industry Research Report 2026

31 December 2025131 pages

Choose your research edition.

Industry ResearchSevere Allergy Treatment Injection Industry Research Report 2026131 pages · $2,950 USDIndustry Growth & TrendsGlobal Severe Allergy Treatment Injection Industry Growth and Trends Forecast to 2032111 pages · $3,450 USDMarket StructureGlobal Severe Allergy Treatment Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Severe Allergy Treatment Injection Market Outlook and Growth Opportunities 2026201 pages · $4,250 USDMarket Analysis & ForecastGlobal Severe Allergy Treatment Injection Market Analysis and Forecast 2026-2032203 pages · $4,950 USD

Market perspective

The global Severe Allergy Treatment Injection market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Severe Allergy Treatment Injection is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Severe Allergy Treatment Injection is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Severe Allergy Treatment Injection is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Severe Allergy Treatment Injection include Grand Pharmaceutical Group, Beijing Yongkang Pharmaceutical, Teva Pharmaceutica, TianJin KingYork Group, Shanghai Harvest Pharmaceutical, Viatris, Teligent, Novartis Sandoz and Nephron Pharmaceuticals Corporation, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Severe Allergy Treatment Injection market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Severe Allergy Treatment Injection Market by Company

Grand Pharmaceutical Group

Beijing Yongkang Pharmaceutical

Teva Pharmaceutica

TianJin KingYork Group

Shanghai Harvest Pharmaceutical

Viatris

Teligent

Novartis Sandoz

Nephron Pharmaceuticals Corporation

Livealth Biopharma

Kaléo

Hameln Pharma

Bioprojet Pharma

Bausch Health

Amneal Pharmaceuticals

ALK Abello

AdvaCare Pharma

Adamis Pharmaceuticals Corporation

Severe Allergy Treatment Injection Segment by Type

Epinephrine Auto-Injectors

Epinephrine Hydrochlaride Injection

Others

Severe Allergy Treatment Injection Segment by Application

Over 12 Years Patients

6 to 12 Years Patients

Under 6 Years Patients

Severe Allergy Treatment Injection Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Severe Allergy Treatment Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Severe Allergy Treatment Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Severe Allergy Treatment Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Severe Allergy Treatment Injection manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Severe Allergy Treatment Injection by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Severe Allergy Treatment Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Severe Allergy Treatment Injection Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Severe Allergy Treatment Injection Sales (K Units) of Manufacturers (2021-2026) Table 7. Global Severe Allergy Treatment Injection Sales Market Share by Manufacturers (2021-2026) Table 8. Global Severe Allergy Treatment Injection Revenue of Manufacturers (2021-2026) Table 9. Global Severe Allergy Treatment Injection Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Severe Allergy Treatment Injection Average Price (US$/Unit) of Manufacturers (2021-2026) Table 11. Global Severe Allergy Treatment Injection Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Severe Allergy Treatment Injection, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Severe Allergy Treatment Injection, Product Type & Application Table 14. Global Severe Allergy Treatment Injection Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Severe Allergy Treatment Injection by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Grand Pharmaceutical Group Company Information Table 19. Grand Pharmaceutical Group Business Overview Table 20. Grand Pharmaceutical Group Severe Allergy Treatment Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 21. Grand Pharmaceutical Group Severe Allergy Treatment Injection Product Portfolio Table 22. Grand Pharmaceutical Group Recent Developments Table 23. Beijing Yongkang Pharmaceutical Company Information Table 24. Beijing Yongkang Pharmaceutical Business Overview Table 25. Beijing Yongkang Pharmaceutical Severe Allergy Treatment Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 26. Beijing Yongkang Pharmaceutical Severe Allergy Treatment Injection Product Portfolio Table 27. Beijing Yongkang Pharmaceutical Recent Developments Table 28. Teva Pharmaceutica Company Information Table 29. Teva Pharmaceutica Business Overview Table 30. Teva Pharmaceutica Severe Allergy Treatment Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 31. Teva Pharmaceutica Severe Allergy Treatment Injection Product Portfolio Table 32. Teva Pharmaceutica Recent Developments Table 33. TianJin KingYork Group Company Information Table 34. TianJin KingYork Group Business Overview Table 35. TianJin KingYork Group Severe Allergy Treatment Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 36. TianJin KingYork Group Severe Allergy Treatment Injection Product Portfolio Table 37. TianJin KingYork Group Recent Developments Table 38. Shanghai Harvest Pharmaceutical Company Information Table 39. Shanghai Harvest Pharmaceutical Business Overview Table 40. Shanghai Harvest Pharmaceutical Severe Allergy Treatment Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 41. Shanghai Harvest Pharmaceutical Severe Allergy Treatment Injection Product Portfolio Table 42. Shanghai Harvest Pharmaceutical Recent Developments Table 43. Viatris Company Information Table 44. Viatris Business Overview Table 45. Viatris Severe Allergy Treatment Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Viatris Severe Allergy Treatment Injection Product Portfolio Table 47. Viatris Recent Developments Table 48. Teligent Company Information Table 49. Teligent Business Overview Table 50. Teligent Severe Allergy Treatment Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 51. Teligent Severe Allergy Treatment Injection Product Portfolio Table 52. Teligent Recent Developments Table 53. Novartis Sandoz Company Information Table 54. Novartis Sandoz Business Overview Table 55. Novartis Sandoz Severe Allergy Treatment Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 56. Novartis Sandoz Severe Allergy Treatment Injection Product Portfolio Table 57. Novartis Sandoz Recent Developments Table 58. Nephron Pharmaceuticals Corporation Company Information Table 59. Nephron Pharmaceuticals Corporation Business Overview Table 60. Nephron Pharmaceuticals Corporation Severe Allergy Treatment Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 61. Nephron Pharmaceuticals Corporation Severe Allergy Treatment Injection Product Portfolio Table 62. Nephron Pharmaceuticals Corporation Recent Developments Table 63. Livealth Biopharma Company Information Table 64. Livealth Biopharma Business Overview Table 65. Livealth Biopharma Severe Allergy Treatment Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Livealth Biopharma Severe Allergy Treatment Injection Product Portfolio Table 67. Livealth Biopharma Recent Developments Table 68. Kaléo Company Information Table 69. Kaléo Business Overview Table 70. Kaléo Severe Allergy Treatment Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. Kaléo Severe Allergy Treatment Injection Product Portfolio Table 72. Kaléo Recent Developments Table 73. Hameln Pharma Company Information Table 74. Hameln Pharma Business Overview Table 75. Hameln Pharma Severe Allergy Treatment Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Hameln Pharma Severe Allergy Treatment Injection Product Portfolio Table 77. Hameln Pharma Recent Developments Table 78. Bioprojet Pharma Company Information Table 79. Bioprojet Pharma Business Overview Table 80. Bioprojet Pharma Severe Allergy Treatment Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Bioprojet Pharma Severe Allergy Treatment Injection Product Portfolio Table 82. Bioprojet Pharma Recent Developments Table 83. Bausch Health Company Information Table 84. Bausch Health Business Overview Table 85. Bausch Health Severe Allergy Treatment Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Bausch Health Severe Allergy Treatment Injection Product Portfolio Table 87. Bausch Health Recent Developments Table 88. Amneal Pharmaceuticals Company Information Table 89. Amneal Pharmaceuticals Business Overview Table 90. Amneal Pharmaceuticals Severe Allergy Treatment Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Amneal Pharmaceuticals Severe Allergy Treatment Injection Product Portfolio Table 92. Amneal Pharmaceuticals Recent Developments Table 93. ALK Abello Company Information Table 94. ALK Abello Business Overview Table 95. ALK Abello Severe Allergy Treatment Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. ALK Abello Severe Allergy Treatment Injection Product Portfolio Table 97. ALK Abello Recent Developments Table 98. AdvaCare Pharma Company Information Table 99. AdvaCare Pharma Business Overview Table 100. AdvaCare Pharma Severe Allergy Treatment Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. AdvaCare Pharma Severe Allergy Treatment Injection Product Portfolio Table 102. AdvaCare Pharma Recent Developments Table 103. Adamis Pharmaceuticals Corporation Company Information Table 104. Adamis Pharmaceuticals Corporation Business Overview Table 105. Adamis Pharmaceuticals Corporation Severe Allergy Treatment Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. Adamis Pharmaceuticals Corporation Severe Allergy Treatment Injection Product Portfolio Table 107. Adamis Pharmaceuticals Corporation Recent Developments Table 108. Global Severe Allergy Treatment Injection Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 109. Global Severe Allergy Treatment Injection Sales by Region (2021-2026) & (K Units) Table 110. Global Severe Allergy Treatment Injection Sales Market Share by Region (2021-2026) Table 111. Global Severe Allergy Treatment Injection Sales by Region (2027-2032) & (K Units) Table 112. Global Severe Allergy Treatment Injection Sales Market Share by Region (2027-2032) Table 113. Global Severe Allergy Treatment Injection Revenue by Region (2021-2026) & (US$ Million) Table 114. Global Severe Allergy Treatment Injection Revenue Market Share by Region (2021-2026) Table 115. Global Severe Allergy Treatment Injection Revenue by Region (2027-2032) & (US$ Million) Table 116. Global Severe Allergy Treatment Injection Revenue Market Share by Region (2027-2032) Table 117. North America Severe Allergy Treatment Injection Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 118. North America Severe Allergy Treatment Injection Sales by Country (2021-2026) & (K Units) Table 119. North America Severe Allergy Treatment Injection Sales by Country (2027-2032) & (K Units) Table 120. North America Severe Allergy Treatment Injection Revenue by Country (2021-2026) & (US$ Million) Table 121. North America Severe Allergy Treatment Injection Revenue by Country (2027-2032) & (US$ Million) Table 122. Europe Severe Allergy Treatment Injection Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 123. Europe Severe Allergy Treatment Injection Sales by Country (2021-2026) & (K Units) Table 124. Europe Severe Allergy Treatment Injection Sales by Country (2027-2032) & (K Units) Table 125. Europe Severe Allergy Treatment Injection Revenue by Country (2021-2026) & (US$ Million) Table 126. Europe Severe Allergy Treatment Injection Revenue by Country (2027-2032) & (US$ Million) Table 127. Asia Pacific Severe Allergy Treatment Injection Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 128. Asia Pacific Severe Allergy Treatment Injection Sales by Country (2021-2026) & (K Units) Table 129. Asia Pacific Severe Allergy Treatment Injection Sales by Country (2027-2032) & (K Units) Table 130. Asia Pacific Severe Allergy Treatment Injection Revenue by Country (2021-2026) & (US$ Million) Table 131. Asia Pacific Severe Allergy Treatment Injection Revenue by Country (2027-2032) & (US$ Million) Table 132. South America Severe Allergy Treatment Injection Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 133. South America Severe Allergy Treatment Injection Sales by Country (2021-2026) & (K Units) Table 134. South America Severe Allergy Treatment Injection Sales by Country (2027-2032) & (K Units) Table 135. South America Severe Allergy Treatment Injection Revenue by Country (2021-2026) & (US$ Million) Table 136. South America Severe Allergy Treatment Injection Revenue by Country (2027-2032) & (US$ Million) Table 137. Middle East and Africa Severe Allergy Treatment Injection Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 138. Middle East and Africa Severe Allergy Treatment Injection Sales by Country (2021-2026) & (K Units) Table 139. Middle East and Africa Severe Allergy Treatment Injection Sales by Country (2027-2032) & (K Units) Table 140. Middle East and Africa Severe Allergy Treatment Injection Revenue by Country (2021-2026) & (US$ Million) Table 141. Middle East and Africa Severe Allergy Treatment Injection Revenue by Country (2027-2032) & (US$ Million) Table 142. Global Severe Allergy Treatment Injection Sales by Type (2021-2026) & (K Units) Table 143. Global Severe Allergy Treatment Injection Sales by Type (2027-2032) & (K Units) Table 144. Global Severe Allergy Treatment Injection Sales Market Share by Type (2021-2026) Table 145. Global Severe Allergy Treatment Injection Sales Market Share by Type (2027-2032) Table 146. Global Severe Allergy Treatment Injection Revenue by Type (2021-2026) & (US$ Million) Table 147. Global Severe Allergy Treatment Injection Revenue by Type (2027-2032) & (US$ Million) Table 148. Global Severe Allergy Treatment Injection Revenue Market Share by Type (2021-2026) Table 149. Global Severe Allergy Treatment Injection Revenue Market Share by Type (2027-2032) Table 150. Global Severe Allergy Treatment Injection Price by Type (2021-2026) & (US$/Unit) Table 151. Global Severe Allergy Treatment Injection Price by Type (2027-2032) & (US$/Unit) Table 152. Global Severe Allergy Treatment Injection Sales by Application (2021-2026) & (K Units) Table 153. Global Severe Allergy Treatment Injection Sales by Application (2027-2032) & (K Units) Table 154. Global Severe Allergy Treatment Injection Sales Market Share by Application (2021-2026) Table 155. Global Severe Allergy Treatment Injection Sales Market Share by Application (2027-2032) Table 156. Global Severe Allergy Treatment Injection Revenue by Application (2021-2026) & (US$ Million) Table 157. Global Severe Allergy Treatment Injection Revenue by Application (2027-2032) & (US$ Million) Table 158. Global Severe Allergy Treatment Injection Revenue Market Share by Application (2021-2026) Table 159. Global Severe Allergy Treatment Injection Revenue Market Share by Application (2027-2032) Table 160. Global Severe Allergy Treatment Injection Price by Application (2021-2026) & (US$/Unit) Table 161. Global Severe Allergy Treatment Injection Price by Application (2027-2032) & (US$/Unit) Table 162. Key Raw Materials Table 163. Raw Materials Key Suppliers Table 164. Severe Allergy Treatment Injection Distributors List Table 165. Severe Allergy Treatment Injection Customers List Table 166. Severe Allergy Treatment Injection Industry Trends Table 167. Severe Allergy Treatment Injection Industry Drivers Table 168. Severe Allergy Treatment Injection Industry Restraints Table 169. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Severe Allergy Treatment Injection Product Image Figure 5. Global Severe Allergy Treatment Injection Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Severe Allergy Treatment Injection Market Size (2021-2032) & (US$ Million) Figure 7. Global Severe Allergy Treatment Injection Sales (2021-2032) & (K Units) Figure 8. Global Severe Allergy Treatment Injection Average Price (US$/Unit) & (2021-2032) Figure 9. Epinephrine Auto-Injectors Product Image Figure 10. Epinephrine Hydrochlaride Injection Product Image Figure 11. Others Product Image Figure 12. Over 12 Years Patients Product Image Figure 13. 6 to 12 Years Patients Product Image Figure 14. Under 6 Years Patients Product Image Figure 15. Global Severe Allergy Treatment Injection Revenue Share by Manufacturers in 2025 Figure 16. Global Manufacturers of Severe Allergy Treatment Injection, Manufacturing Sites & Headquarters Figure 17. Global Top 5 and 10 Severe Allergy Treatment Injection Players Market Share by Revenue in 2025 Figure 18. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 19. Global Severe Allergy Treatment Injection Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 20. Global Severe Allergy Treatment Injection Sales by Region in 2025 Figure 21. Global Severe Allergy Treatment Injection Revenue by Region in 2025 Figure 22. North America Severe Allergy Treatment Injection Market Size by Country in 2025 Figure 23. North America Severe Allergy Treatment Injection Sales Market Share by Country (2021-2032) Figure 24. North America Severe Allergy Treatment Injection Revenue Market Share by Country (2021-2032) Figure 25. United States Severe Allergy Treatment Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 26. Canada Severe Allergy Treatment Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 27. Europe Severe Allergy Treatment Injection Market Size by Country in 2025 Figure 28. Europe Severe Allergy Treatment Injection Sales Market Share by Country (2021-2032) Figure 29. Europe Severe Allergy Treatment Injection Revenue Market Share by Country (2021-2032) Figure 30. Germany Severe Allergy Treatment Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 31. France Severe Allergy Treatment Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 32. U.K. Severe Allergy Treatment Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. Italy Severe Allergy Treatment Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. Netherlands Severe Allergy Treatment Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. Nordic Countries Severe Allergy Treatment Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. Asia Pacific Severe Allergy Treatment Injection Market Size by Country in 2025 Figure 37. Asia Pacific Severe Allergy Treatment Injection Sales Market Share by Country (2021-2032) Figure 38. Asia Pacific Severe Allergy Treatment Injection Revenue Market Share by Country (2021-2032) Figure 39. China Severe Allergy Treatment Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. Japan Severe Allergy Treatment Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 41. South Korea Severe Allergy Treatment Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 42. India Severe Allergy Treatment Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 43. Australia Severe Allergy Treatment Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 44. China Taiwan Severe Allergy Treatment Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 45. Southeast Asia Severe Allergy Treatment Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. Southeast Asia Severe Allergy Treatment Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. South America Severe Allergy Treatment Injection Market Size by Country in 2025 Figure 48. South America Severe Allergy Treatment Injection Sales Market Share by Country (2021-2032) Figure 49. South America Severe Allergy Treatment Injection Revenue Market Share by Country (2021-2032) Figure 50. Mexico Severe Allergy Treatment Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. Brazil Severe Allergy Treatment Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 52. Argentina Severe Allergy Treatment Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 53. Middle East and Africa Severe Allergy Treatment Injection Market Size by Country in 2025 Figure 54. Middle East and Africa Severe Allergy Treatment Injection Sales Market Share by Country (2021-2032) Figure 55. Middle East and Africa Severe Allergy Treatment Injection Revenue Market Share by Country (2021-2032) Figure 56. Turkey Severe Allergy Treatment Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 57. Saudi Arabia Severe Allergy Treatment Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 58. UAE Severe Allergy Treatment Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 59. Global Severe Allergy Treatment Injection Sales Market Share by Type (2021-2032) Figure 60. Global Severe Allergy Treatment Injection Revenue Market Share by Type (2021-2032) Figure 61. Global Severe Allergy Treatment Injection Price (US$/Unit) by Type (2021-2032) Figure 62. Global Severe Allergy Treatment Injection Sales Market Share by Application (2021-2032) Figure 63. Global Severe Allergy Treatment Injection Revenue Market Share by Application (2021-2032) Figure 64. Global Severe Allergy Treatment Injection Price (US$/Unit) by Application (2021-2032) Figure 65. Severe Allergy Treatment Injection Value Chain Figure 66. Severe Allergy Treatment Injection Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Severe Allergy Treatment Injection Industry Opportunities and Challenges

Scope & coverage.

Types
  • Epinephrine Auto-Injectors
  • Epinephrine Hydrochlaride Injection
  • Others
Applications
  • Over 12 Years Patients
  • 6 to 12 Years Patients
  • Under 6 Years Patients
Companies covered
  • Grand Pharmaceutical Group
  • Beijing Yongkang Pharmaceutical
  • Teva Pharmaceutica
  • TianJin KingYork Group
  • Shanghai Harvest Pharmaceutical
  • Viatris
  • Teligent
  • Novartis Sandoz
  • Nephron Pharmaceuticals Corporation
  • Livealth Biopharma
  • Kaléo
  • Hameln Pharma
  • Bioprojet Pharma
  • Bausch Health
  • Amneal Pharmaceuticals
  • ALK Abello
  • AdvaCare Pharma
  • Adamis Pharmaceuticals Corporation

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Severe Allergy Treatment Injection Market Size (2021-2032)
  4. 2.2.2 Global Severe Allergy Treatment Injection Sales (2021-2032)
  5. 2.2.3 Global Severe Allergy Treatment Injection Market Average Price (2021-2032)
  6. 2.3 Severe Allergy Treatment Injection by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Epinephrine Auto-Injectors
  9. 2.3.3 Epinephrine Hydrochlaride Injection
  10. 2.3.4 Others
  11. 2.4 Severe Allergy Treatment Injection by Application
  12. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  13. 2.4.2 Over 12 Years Patients
  14. 2.4.3 6 to 12 Years Patients
  15. 2.4.4 Under 6 Years Patients
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Severe Allergy Treatment Injection Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Severe Allergy Treatment Injection Sales (K Units) of Manufacturers (2021-2026)
  3. 3.3 Global Severe Allergy Treatment Injection Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Severe Allergy Treatment Injection Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Severe Allergy Treatment Injection Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Severe Allergy Treatment Injection, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Severe Allergy Treatment Injection, Product Type & Application
  8. 3.8 Global Manufacturers of Severe Allergy Treatment Injection, Established Date
  9. 3.9 Global Severe Allergy Treatment Injection Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Grand Pharmaceutical Group
  2. 4.1.1 Grand Pharmaceutical Group Company Information
  3. 4.1.2 Grand Pharmaceutical Group Business Overview
  4. 4.1.3 Grand Pharmaceutical Group Severe Allergy Treatment Injection Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Grand Pharmaceutical Group Severe Allergy Treatment Injection Product Portfolio
  6. 4.1.5 Grand Pharmaceutical Group Recent Developments
  7. 4.2 Beijing Yongkang Pharmaceutical
  8. 4.2.1 Beijing Yongkang Pharmaceutical Company Information
  9. 4.2.2 Beijing Yongkang Pharmaceutical Business Overview
  10. 4.2.3 Beijing Yongkang Pharmaceutical Severe Allergy Treatment Injection Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Beijing Yongkang Pharmaceutical Severe Allergy Treatment Injection Product Portfolio
  12. 4.2.5 Beijing Yongkang Pharmaceutical Recent Developments
  13. 4.3 Teva Pharmaceutica
  14. 4.3.1 Teva Pharmaceutica Company Information
  15. 4.3.2 Teva Pharmaceutica Business Overview
  16. 4.3.3 Teva Pharmaceutica Severe Allergy Treatment Injection Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Teva Pharmaceutica Severe Allergy Treatment Injection Product Portfolio
  18. 4.3.5 Teva Pharmaceutica Recent Developments
  19. 4.4 TianJin KingYork Group
  20. 4.4.1 TianJin KingYork Group Company Information
  21. 4.4.2 TianJin KingYork Group Business Overview
  22. 4.4.3 TianJin KingYork Group Severe Allergy Treatment Injection Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 TianJin KingYork Group Severe Allergy Treatment Injection Product Portfolio
  24. 4.4.5 TianJin KingYork Group Recent Developments
  25. 4.5 Shanghai Harvest Pharmaceutical
  26. 4.5.1 Shanghai Harvest Pharmaceutical Company Information
  27. 4.5.2 Shanghai Harvest Pharmaceutical Business Overview
  28. 4.5.3 Shanghai Harvest Pharmaceutical Severe Allergy Treatment Injection Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Shanghai Harvest Pharmaceutical Severe Allergy Treatment Injection Product Portfolio
  30. 4.5.5 Shanghai Harvest Pharmaceutical Recent Developments
  31. 4.6 Viatris
  32. 4.6.1 Viatris Company Information
  33. 4.6.2 Viatris Business Overview
  34. 4.6.3 Viatris Severe Allergy Treatment Injection Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Viatris Severe Allergy Treatment Injection Product Portfolio
  36. 4.6.5 Viatris Recent Developments
  37. 4.7 Teligent
  38. 4.7.1 Teligent Company Information
  39. 4.7.2 Teligent Business Overview
  40. 4.7.3 Teligent Severe Allergy Treatment Injection Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 Teligent Severe Allergy Treatment Injection Product Portfolio
  42. 4.7.5 Teligent Recent Developments
  43. 4.8 Novartis Sandoz
  44. 4.8.1 Novartis Sandoz Company Information
  45. 4.8.2 Novartis Sandoz Business Overview
  46. 4.8.3 Novartis Sandoz Severe Allergy Treatment Injection Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 Novartis Sandoz Severe Allergy Treatment Injection Product Portfolio
  48. 4.8.5 Novartis Sandoz Recent Developments
  49. 4.9 Nephron Pharmaceuticals Corporation
  50. 4.9.1 Nephron Pharmaceuticals Corporation Company Information
  51. 4.9.2 Nephron Pharmaceuticals Corporation Business Overview
  52. 4.9.3 Nephron Pharmaceuticals Corporation Severe Allergy Treatment Injection Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 Nephron Pharmaceuticals Corporation Severe Allergy Treatment Injection Product Portfolio
  54. 4.9.5 Nephron Pharmaceuticals Corporation Recent Developments
  55. 4.10 Livealth Biopharma
  56. 4.10.1 Livealth Biopharma Company Information
  57. 4.10.2 Livealth Biopharma Business Overview
  58. 4.10.3 Livealth Biopharma Severe Allergy Treatment Injection Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 Livealth Biopharma Severe Allergy Treatment Injection Product Portfolio
  60. 4.10.5 Livealth Biopharma Recent Developments
  61. 4.11 Kaléo
  62. 4.11.1 Kaléo Company Information
  63. 4.11.2 Kaléo Business Overview
  64. 4.11.3 Kaléo Severe Allergy Treatment Injection Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 Kaléo Severe Allergy Treatment Injection Product Portfolio
  66. 4.11.5 Kaléo Recent Developments
  67. 4.12 Hameln Pharma
  68. 4.12.1 Hameln Pharma Company Information
  69. 4.12.2 Hameln Pharma Business Overview
  70. 4.12.3 Hameln Pharma Severe Allergy Treatment Injection Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 Hameln Pharma Severe Allergy Treatment Injection Product Portfolio
  72. 4.12.5 Hameln Pharma Recent Developments
  73. 4.13 Bioprojet Pharma
  74. 4.13.1 Bioprojet Pharma Company Information
  75. 4.13.2 Bioprojet Pharma Business Overview
  76. 4.13.3 Bioprojet Pharma Severe Allergy Treatment Injection Sales, Revenue and Gross Margin (2021-2026)
  77. 4.13.4 Bioprojet Pharma Severe Allergy Treatment Injection Product Portfolio
  78. 4.13.5 Bioprojet Pharma Recent Developments
  79. 4.14 Bausch Health
  80. 4.14.1 Bausch Health Company Information
  81. 4.14.2 Bausch Health Business Overview
  82. 4.14.3 Bausch Health Severe Allergy Treatment Injection Sales, Revenue and Gross Margin (2021-2026)
  83. 4.14.4 Bausch Health Severe Allergy Treatment Injection Product Portfolio
  84. 4.14.5 Bausch Health Recent Developments
  85. 4.15 Amneal Pharmaceuticals
  86. 4.15.1 Amneal Pharmaceuticals Company Information
  87. 4.15.2 Amneal Pharmaceuticals Business Overview
  88. 4.15.3 Amneal Pharmaceuticals Severe Allergy Treatment Injection Sales, Revenue and Gross Margin (2021-2026)
  89. 4.15.4 Amneal Pharmaceuticals Severe Allergy Treatment Injection Product Portfolio
  90. 4.15.5 Amneal Pharmaceuticals Recent Developments
  91. 4.16 ALK Abello
  92. 4.16.1 ALK Abello Company Information
  93. 4.16.2 ALK Abello Business Overview
  94. 4.16.3 ALK Abello Severe Allergy Treatment Injection Sales, Revenue and Gross Margin (2021-2026)
  95. 4.16.4 ALK Abello Severe Allergy Treatment Injection Product Portfolio
  96. 4.16.5 ALK Abello Recent Developments
  97. 4.17 AdvaCare Pharma
  98. 4.17.1 AdvaCare Pharma Company Information
  99. 4.17.2 AdvaCare Pharma Business Overview
  100. 4.17.3 AdvaCare Pharma Severe Allergy Treatment Injection Sales, Revenue and Gross Margin (2021-2026)
  101. 4.17.4 AdvaCare Pharma Severe Allergy Treatment Injection Product Portfolio
  102. 4.17.5 AdvaCare Pharma Recent Developments
  103. 4.18 Adamis Pharmaceuticals Corporation
  104. 4.18.1 Adamis Pharmaceuticals Corporation Company Information
  105. 4.18.2 Adamis Pharmaceuticals Corporation Business Overview
  106. 4.18.3 Adamis Pharmaceuticals Corporation Severe Allergy Treatment Injection Sales, Revenue and Gross Margin (2021-2026)
  107. 4.18.4 Adamis Pharmaceuticals Corporation Severe Allergy Treatment Injection Product Portfolio
  108. 4.18.5 Adamis Pharmaceuticals Corporation Recent Developments
5 Global Severe Allergy Treatment Injection Market Scenario by Region
  1. 5.1 Global Severe Allergy Treatment Injection Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Severe Allergy Treatment Injection Sales by Region: 2021-2032
  3. 5.2.1 Global Severe Allergy Treatment Injection Sales by Region: 2021-2026
  4. 5.2.2 Global Severe Allergy Treatment Injection Sales by Region: 2027-2032
  5. 5.3 Global Severe Allergy Treatment Injection Revenue by Region: 2021-2032
  6. 5.3.1 Global Severe Allergy Treatment Injection Revenue by Region: 2021-2026
  7. 5.3.2 Global Severe Allergy Treatment Injection Revenue by Region: 2027-2032
  8. 5.4 North America Severe Allergy Treatment Injection Market Facts & Figures by Country
  9. 5.4.1 North America Severe Allergy Treatment Injection Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Severe Allergy Treatment Injection Sales by Country (2021-2032)
  11. 5.4.3 North America Severe Allergy Treatment Injection Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.5 Europe Severe Allergy Treatment Injection Market Facts & Figures by Country
  15. 5.5.1 Europe Severe Allergy Treatment Injection Market Size by Country: 2021 VS 2025 VS 2032
  16. 5.5.2 Europe Severe Allergy Treatment Injection Sales by Country (2021-2032)
  17. 5.5.3 Europe Severe Allergy Treatment Injection Revenue by Country (2021-2032)
  18. 5.5.4 Germany
  19. 5.5.5 France
  20. 5.5.6 U.K.
  21. 5.5.7 Italy
  22. 5.5.8 Netherlands
  23. 5.5.9 Nordic Countries
  24. 5.6 Asia Pacific Severe Allergy Treatment Injection Market Facts & Figures by Country
  25. 5.6.1 Asia Pacific Severe Allergy Treatment Injection Market Size by Country: 2021 VS 2025 VS 2032
  26. 5.6.2 Asia Pacific Severe Allergy Treatment Injection Sales by Country (2021-2032)
  27. 5.6.3 Asia Pacific Severe Allergy Treatment Injection Revenue by Country (2021-2032)
  28. 5.6.4 China
  29. 5.6.5 Japan
  30. 5.6.6 South Korea
  31. 5.6.7 India
  32. 5.6.8 Australia
  33. 5.6.9 China Taiwan
  34. 5.6.10 Southeast Asia
  35. 5.7 South America Severe Allergy Treatment Injection Market Facts & Figures by Country
  36. 5.7.1 South America Severe Allergy Treatment Injection Market Size by Country: 2021 VS 2025 VS 2032
  37. 5.7.2 South America Severe Allergy Treatment Injection Sales by Country (2021-2032)
  38. 5.7.3 South America Severe Allergy Treatment Injection Revenue by Country (2021-2032)
  39. 5.7.4 Mexico
  40. 5.7.5 Brazil
  41. 5.7.6 Argentina
  42. 5.8 Middle East and Africa Severe Allergy Treatment Injection Market Facts & Figures by Country
  43. 5.8.1 Middle East and Africa Severe Allergy Treatment Injection Market Size by Country: 2021 VS 2025 VS 2032
  44. 5.8.2 Middle East and Africa Severe Allergy Treatment Injection Sales by Country (2021-2032)
  45. 5.8.3 Middle East and Africa Severe Allergy Treatment Injection Revenue by Country (2021-2032)
  46. 5.8.4 Turkey
  47. 5.8.5 Saudi Arabia
  48. 5.8.6 UAE
6 Segment by Type
  1. 6.1 Global Severe Allergy Treatment Injection Sales by Type (2021-2032)
  2. 6.1.1 Global Severe Allergy Treatment Injection Sales by Type (2021-2032) & (K Units)
  3. 6.1.2 Global Severe Allergy Treatment Injection Sales Market Share by Type (2021-2032)
  4. 6.2 Global Severe Allergy Treatment Injection Revenue by Type (2021-2032)
  5. 6.2.1 Global Severe Allergy Treatment Injection Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Severe Allergy Treatment Injection Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Severe Allergy Treatment Injection Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Severe Allergy Treatment Injection Sales by Application (2021-2032)
  2. 7.1.1 Global Severe Allergy Treatment Injection Sales by Application (2021-2032) & (K Units)
  3. 7.1.2 Global Severe Allergy Treatment Injection Sales Market Share by Application (2021-2032)
  4. 7.2 Global Severe Allergy Treatment Injection Revenue by Application (2021-2032)
  5. 7.2.1 Global Severe Allergy Treatment Injection Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Severe Allergy Treatment Injection Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Severe Allergy Treatment Injection Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Severe Allergy Treatment Injection Value Chain Analysis
  2. 8.1.1 Severe Allergy Treatment Injection Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Severe Allergy Treatment Injection Production Mode & Process
  5. 8.2 Severe Allergy Treatment Injection Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Severe Allergy Treatment Injection Distributors
  8. 8.2.3 Severe Allergy Treatment Injection Customers
9 Global Severe Allergy Treatment Injection Analyzing Market Dynamics
  1. 9.1 Severe Allergy Treatment Injection Industry Trends
  2. 9.2 Severe Allergy Treatment Injection Industry Drivers
  3. 9.3 Severe Allergy Treatment Injection Industry Opportunities and Challenges
  4. 9.4 Severe Allergy Treatment Injection Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst